P

POXEL

44 employees

Poxel is a research integrated pharmaceutical company that develops products for metabolic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
direct adenosine monophosphate-activated protein kinase activator.
Type 2 Diabetes
Metabolic Diseases
AMPK
Pharmaceutical
NASH
non-alcoholic steatohepatitis

Date founded

2009

Funding rounds raised

Total raised

$21M

from 7 investors over 7 rounds

P

POXEL raised undisclosed on August 8, 2022

Investors: IPF Partners

P

POXEL raised $14M on September 9, 2014

Investors: Andera Partners and Kreos Capital

P

POXEL raised $17M on December 18, 2012

Investors: Omnes and Andera Partners

P

POXEL raised $21M on July 8, 2010

Investors: Omnes and Andera Partners

FAQ